Schrödinger, Inc. (SDGR)

NASDAQ: SDGR · IEX Real-Time Price · USD
21.41
-0.38 (-1.74%)
Jul 19, 2024, 11:17 AM EDT - Market open
-1.74%
Market Cap 1.56B
Revenue (ttm) 188.48M
Net Income (ttm) -143.14M
Shares Out 72.68M
EPS (ttm) -1.97
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 91,057
Open 21.88
Previous Close 21.79
Day's Range 21.31 - 21.98
52-Week Range 18.21 - 54.94
Beta 1.51
Analysts Buy
Price Target 38.90 (+81.69%)
Earnings Date Jul 31, 2024

About SDGR

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serv... [Read more]

Sector Healthcare
IPO Date Feb 6, 2020
Employees 867
Stock Exchange NASDAQ
Ticker Symbol SDGR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for SDGR stock is "Buy." The 12-month stock price forecast is $38.9, which is an increase of 81.69% from the latest price.

Price Target
$38.9
(81.69% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Schrödinger to Announce Second Quarter 2024 Financial Results on July 31

NEW YORK--(BUSINESS WIRE)--Schrödinger will report its second quarter 2024 financial results on Wednesday, July 31, 2024, after the financial markets close.

2 days ago - Business Wire

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger today reported that on July 12, 2024, the company granted restricted stock units (RSUs).

3 days ago - Business Wire

Schrödinger to Present at Jefferies Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference.

2 months ago - Business Wire

Schrödinger Reports First Quarter 2024 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced financial results for the first quarter of 2024.

2 months ago - Business Wire

Schrödinger to Announce First Quarter 2024 Financial Results on May 1

NEW YORK--(BUSINESS WIRE)--Schrödinger will report its first quarter 2024 financial results on Wednesday, May 1, 2024, after the financial markets close.

3 months ago - Business Wire

Schrödinger Reports Strong Fourth Quarter and Full-Year 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced financial results for the fourth quarter and full-year and provided its financial outlook for 2024.

5 months ago - Business Wire

Schrödinger to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28

NEW YORK--(BUSINESS WIRE)--Schrödinger will report its fourth quarter and full-year 2023 financial results on Wednesday, February 28, 2024.

5 months ago - Business Wire

Schrödinger Reports Third Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced financial res...

9 months ago - Business Wire

Schrödinger to Announce Third Quarter 2023 Financial Results on November 1

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced it will report third quarter 2023 financial results on November 1, 2023.

9 months ago - Business Wire

The Good And Bad: Allison Transmission & Schrodinger Inc.

See two of the featured stocks from this month's model portfolios.

Other symbols: ALSN
10 months ago - Forbes

Schrödinger Reports Second Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. today announced financial results for the quarter ended on June 30, 2023.

1 year ago - Business Wire

Biotech Stocks Join AI-Fueled Rally

Shares of Recursion Pharmaceuticals, Schrodinger and others that are implementing AI are surging.

Other symbols: RXRX
1 year ago - WSJ

Schrödinger to Announce Second Quarter 2023 Financial Results on August 2

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2023...

1 year ago - Business Wire

Schrödinger Reports Strong First Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced financial res...

1 year ago - Business Wire

Schrödinger Publishes Inaugural Corporate Sustainability Report

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today published its inaugural...

1 year ago - Business Wire

Schrödinger to Announce First Quarter 2023 Financial Results on May 4

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2023 ...

1 year ago - Business Wire

Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced financial res...

1 year ago - Business Wire

Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on Februa...

1 year ago - Business Wire

Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus's TYK2 Inhibitor to Takeda

NEW YORK--(BUSINESS WIRE)--Schrödinger Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported the receipt of ...

1 year ago - Business Wire

Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its fourth quarter and ...

1 year ago - Business Wire

Schrödinger to Present at SVB Securities Global Biopharma Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management w...

1 year ago - Business Wire

Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today provided an update on...

1 year ago - Business Wire

Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced new preclin...

1 year ago - Business Wire

Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management w...

1 year ago - Business Wire

Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger today announced that management will participate in the Jefferies 13th Annual London Healthcare Conference in London, UK.

1 year ago - Business Wire